The White Paper of Mediex and other website contents, including affiliate websites, neither solicit for participation nor offer any investment opportunity to its participant. Participants are requested to read the contents of the website carefully.
The website and white paper prepared by Mediex is for informational purposes only, and is not an offer or a solicitation to buy or sell any securities or to invest in any financial instruments.
The tokens so gained by the participant the Mediex services are not intended to afford the participant any right or claim of the assets or profit thereof of Mediex and shall not be treated as a security, investment tool, promissory note, bill of exchange, share, scrip, debenture or any other financial instrument that may entail any beneficial interest to the participant of the Mediex services at any point of time.
The registration on the Mediex platform permits access to the services provided by the platform as detailed in the MDX Token Generation Event General Terms and Conditions, Cookie Policies and the information available on the website.
Mediex will diligently endeavor to achieve the vision and the benchmarks envisaged in the white paper and website, which will be achieved in a phased manner periodically. However, a target date for the achievement of vision and benchmarks is not possible to declare any time.
Mediex is a service platform developed on the Ethereum’s blockchain platform. However, the token and other aspects of our technology may have different financial and legal treatment in the participant’s Country, therefore, the participant is advised to understand the legal implication of transaction carried out at www.Mediex.io or any third party platform through Mediex tokens all the time.
The sale of token and transaction on www.Mediex .io may be restricted or suspended, temporarily or permanently, in the regions wherein the Mediex’s platform is declared to be in conflict with the laws of the restricting region, which is unlikely in future.
Participant/s acknowledges that the Mediex platform, as described herein, may never in fact operate as intended. Participant/s also acknowledges that all services and scope of work proposed in this white paper is subject to any licensing required.
The white paper has been prepared to the best of our knowledge and research, however it should not be relied upon for any future actions.
Mediex’s founders, advisors or affiliates shall not be liable for any losses that arise in any way due to the use of this document or the contents contained herein. Mediex may share the data of the Participants.